As the first line of defence against pathogens, cells mount an innate immune response, which varies widely from cell to cell. The response must be potent but carefully controlled to avoid self-damage. How these constraints have shaped the evolution of innate immunity remains poorly understood. Here we characterize the innate immune response's transcriptional divergence between species and variability in expression among cells. Using bulk and single-cell transcriptomics in fibroblasts and mononuclear phagocytes from different species, challenged with immune stimuli, we map the architecture of the innate immune response. Transcriptionally diverging genes, including those that encode cytokines and chemokines, vary across cells and have distinct promoter structures. Conversely, genes that are involved in the regulation of this response, such as those that encode transcription factors and kinases, are conserved between species and display low cell-to-cell variability in expression. We suggest that this expression pattern, which is observed across species and conditions, has evolved as a mechanism for fine-tuned regulation to achieve an effective but balanced response. P = 1 P = 0.94 P = 0.27 1 9 8 | N A t U r e | V O l 5 6 3 | 8 N O V e M B e r 2 0 1 8
The innate immune response is a cell-intrinsic defence program that is rapidly upregulated upon infection in most cell types. It acts to inhibit pathogen replication while signalling the pathogen's presence to other cells. This programme involves the modulation of several cellular pathways, including production of antiviral and inflammatory cytokines, upregulation of genes that restrict pathogens, and induction of cell death 1, 2 .
An important characteristic of the innate immune response is the rapid evolution that many of its genes have undergone along the vertebrate lineage 3, 4 . This rapid evolution is often attributed to pathogen-driven selection [5] [6] [7] .
Another hallmark of this response is its high level of heterogeneity among responding cells: there is extensive cell-to-cell variability in response to pathogen infection 8, 9 or to pathogen-associated molecular patterns (PAMPs) 10, 11 . The functional importance of this variability is unclear.
These two characteristics-rapid divergence in the course of evolution and high cell-to-cell variability-seem to be at odds with the strong regulatory constraints imposed on the host immune response: the need to execute a well-coordinated and carefully balanced programme to avoid tissue damage and pathological immune conditions [12] [13] [14] [15] . How this tight regulation is maintained despite rapid evolutionary divergence and high cell-to-cell variability remains unclear, but it is central to our understanding of the innate immune response and its evolution.
Here, we study the evolution of this programme using two cells types-fibroblasts and mononuclear phagocytes-in different mammalian clades challenged with several immune stimuli (Fig. 1a ). Our main experimental system uses primary dermal fibroblasts, which are commonly used in immunological studies 8, 13 . We compare the response of fibroblasts from primates (human and macaque) and rodents (mouse and rat) to polyinosinic:polycytidylic acid (poly(I:C)), a synthetic double-stranded RNA (dsRNA; Fig. 1a , left). Poly(I:C) is frequently used to mimic viral infection as it rapidly elicits an antiviral response 16 .
We comprehensively characterize the transcriptional changes between species and among individual cells in their innate immune response. We use population (bulk) transcriptomics to investigate transcriptional divergence between species, and single-cell transcriptomics to estimate cell-to-cell variability in gene expression. Using promoter sequence analyses along with chromatin immunoprecipitation with sequencing (ChIP-seq), we study how changes in the expression of each gene between species and across cells relate to the architecture of its promoter. Furthermore, we examine the relationship between cross-species divergence in gene coding sequence and expression and constraints imposed by host-pathogen interactions.
Additionally, we use a second system-bone marrow-derived mononuclear phagocytes from mouse, rat, rabbit and pig challenged with lipopolysaccharide (LPS), a commonly used PAMP of bacterial origin (Fig. 1a, right) .
Together, these two systems provide insights into the architecture of the immune response across species, cell types and immune challenges.
Transcriptional divergence in immune response
First, we studied the transcriptional response of fibroblasts to stimulation with dsRNA (poly(I:C)) across the four species (human, macaque, Article reSeArcH rat and mouse). We generated bulk RNA-sequencing (RNA-seq) data for each species after 4 h of stimulation, along with respective controls (see Fig. 1a and Methods).
In all species, dsRNA treatment induced rapid upregulation of genes that encode expected antiviral and inflammatory products, including IFNB, TNF, IL1A and CCL5 (see also Supplementary Table 3 ). Focusing on one-to-one orthologues, we performed correlation analysis between species and observed a similar transcriptional response (Spearman correlation, P < 10 −10 in all comparisons; Extended Data Fig. 1 ), as reported in other immune contexts [17] [18] [19] . Furthermore, the response tended to be more strongly correlated between closely related species than between more distantly related species, as in other expression programmes [20] [21] [22] [23] [24] .
We characterized the differences in response to dsRNA between species for each gene, using these cross-species bulk transcriptomics data. While some genes, such as those encoding the NF-κB subunits RELB and NFKB2, respond similarly across species, other genes respond differently in the primate and rodent clades (Fig. 1b, left) . For example, Ifi27 (which encodes a restriction factor against numerous viruses) is strongly upregulated in primates but not in rodents, whereas Daxx (which encodes an antiviral transcriptional repressor) exhibits the opposite behaviour.
Similarly, in our second experimental system, which consists of lipopolysaccharide (LPS)-stimulated mononuclear phagocytes from mouse, rat, rabbit, and pig ( Fig. 1b, right) , some genes responded similarly across species (for example, Nfkb2), whereas others were highly upregulated only in specific clades (for example, Phlda1).
To quantify transcriptional divergence in immune responses between species, we focused on genes that were differentially expressed during the stimulation (see Methods). For simplicity, we refer to these genes as 'responsive genes' (Fig. 1c ). In this analysis, we study the subset of these genes with one-to-one orthologues across the studied species. There are 955 such responsive genes in dsRNA-stimulated human fibroblasts and 2,336 in LPS-stimulated mouse phagocytes. We define a measure of response divergence by calculating the differences between the fold-change estimates while taking the phylogenetic relationship into account (Methods, Supplementary Figs. 1-7 and Supplementary  Table 4 ).
For subsequent analyses, we split the 955 genes that were responsive in fibroblasts into three groups on the basis of their level of response divergence: (1) high-divergence dsRNA-responsive genes (the top 25% of genes with the highest divergence values in response to dsRNA across the four studied species); (2) low-divergence dsRNA-responsive genes (the bottom 25%); and (3) genes with medium divergence across species (the middle 50%; Fig. 1c ). We performed an analogous procedure for the 2,336 LPS-responsive genes in phagocytes.
Promoter architecture of diverging genes
Next, we tested whether divergence in transcriptional responses is reflected in the conservation of promoter function and sequence. Using ChIP-seq, we profiled active histone marks in the fibroblasts of all species. The presence of trimethylation of lysine 4 on histone H3 (H3K4me3) in promoter regions of high-divergence genes was significantly less conserved between humans and rodents than was the presence of H3K4me3 in promoters of low-divergence genes (Extended Data Fig. 2) .
We then used the human H3K4me3 ChIP-seq peaks to define active promoter regions of the responsive genes in human fibroblasts. The density of transcription factor binding motifs (TFBMs) was significantly higher in the active promoter regions of high-divergence genes than in low-divergence genes ( Fig. 2a ). Notably, when comparing the conservation of the core promoter regions in high-versus lowdivergence dsRNA-responsive genes, we found that genes that diverge highly in response to dsRNA show higher sequence conservation in this region ( Fig. 2b ).
This unexpected discordance may be related to the fact that promoters of high-and low-divergence genes have distinctive architectures, associated with different constraints on promoter sequence evolution 18, 25, 26 . Notably, promoters containing TATA-box elements tend to have most of their regulatory elements in regions immediately upstream of the transcription start site (TSS). These promoters are thus expected to be more conserved. The opposite is true for CpG island (CGI) 26, 27 promoters. Indeed, we found that TATA-boxes are associated with higher transcriptional divergence, while genes with CGIs diverge more slowly, both in fibroblasts and phagocytes ( Fig. 2c ; Extended Data Fig. 3 ). Thus, a promoter architecture enriched in TATA-boxes and depleted of CGIs is associated with higher transcriptional divergence, while entailing higher sequence conservation upstream of these genes 18, 26, 27 .
Transcriptional divergence of cytokines
We next investigated whether different functional classes among responsive genes are characterized by varying levels of transcriptional divergence. To this end, we divided responsive genes into categories according to function (such as cytokines, transcriptional factors and kinases) or the processes in which they are known to be involved (such as apoptosis or inflammation). Left, primary dermal fibroblasts from mouse, rat, human and macaque stimulated with dsRNA or controls. Samples were collected for bulk and single-cell RNA-seq and ChIP-seq. Right, primary bone marrow-derived mononuclear phagocytes from mouse, rat, rabbit and pig stimulated with LPS or controls. Samples were collected for bulk and single-cell RNA-seq. b, Left, fold-change (FC) in dsRNA stimulation in fibroblasts for sample genes across species (edgeR exact test, based on n = 6, 5, 3 and 3 individuals from human, macaque, rat and mouse, respectively). Right, fold-change in LPS stimulation in phagocytes for sample genes across species (Wald test implemented in DESeq2, based on n = 3 individuals from each species). False discovery rate (FDR)corrected P values are shown (***P < 0.001, **P < 0.01, *P < 0.05). c, Top, estimating each gene's level of cross-species divergence in transcriptional response to dsRNA stimulation in fibroblasts. Using differential expression analysis, fold-change in dsRNA response was assessed for each gene in each species. We identified 1,358 human genes as differentially expressed (DE) (FDR-corrected q < 0.01), of which 955 had one-to-one orthologues across the four studied species. For each gene with one-toone orthologues across all species, a response divergence measure was estimated using: 
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Genes related to cellular defence and inflammation-most notably cytokines, chemokines and their receptors (hereafter 'cytokines')tended to diverge in response significantly faster than genes involved in apoptosis or immune regulation (chromatin modulators, transcription factors, kinases and ligases) ( Fig. 2d , e, Extended Data Fig. 4 , Supplementary Fig. 1 ).
Cytokines also had a higher transcriptional range in response to immune challenge (a higher fold-change). Regressing the fold-change from the divergence estimates resulted in reduction of the relative divergence of cytokines versus other responsive genes, but the difference still remained ( Supplementary Fig. 2 ). Cytokine promoters are enriched in TATA-boxes (17% versus 2.5%, P = 1.1 × 10 −3 , Fisher's exact test) and depleted of CGIs (14% versus 69%, P = 1.6 × 10 −9 ), suggesting that this promoter architecture is associated both with greater differences between species (response divergence) and larger changes between conditions (transcriptional range).
Cell-to-cell variability in immune response
Previous studies have shown that the innate immune response displays high variability across responding cells 28, 29 . However, the relationship between cell-to-cell transcriptional variability and response divergence between species is not well understood.
To study heterogeneity in gene expression across individual cells, we performed single-cell RNA-seq in all species in a time course following immune stimulation. We estimated cell-to-cell variability quantitatively using an established measure for variability: distance to median (DM) 30 .
We found a clear trend in which genes that were highly divergent in response between species were also more variable in expression across individual cells within a species (Fig. 3a) . The relationship between rapid divergence and high cell-to-cell variability held true in both the 955 dsRNA-responsive genes in fibroblasts and the 2,336 LPS-responsive genes in phagocytes. This can be observed across the stimulation time points and in different species (Extended Data Figs. 5, 6) . We analysed in depth the relationship between transcriptional divergence and cell-to-cell variability by using additional immune stimulation protocols (Supplementary Figs. 8, 9) , and different experimental and computational approaches (Extended Data Fig. 7 , Supplementary Figs. [10] [11] [12] [13] . Notably, the trends we observed are not a result of technical biases due to low expression levels in either the bulk or the single-cell RNA-seq data ( Supplementary Figs. 14, 15 ).
Next, we examined the relationship between the presence of promoter elements (CGIs and TATA-boxes) and a gene's cell-to-cell variability. Genes that are predicted to have a TATA-box in their promoter had higher transcriptional variability, whereas CGI-containing genes tended to have lower variability ( Fig. 3b ), in agreement with previous findings 31 . Thus, both transcriptional variability between cells ( Fig. 3b ) and transcriptional divergence between species ( Fig. 2c ) are associated with the presence of specific promoter elements.
Transcriptional variability of cytokines
We subsequently compared the response divergence across species with the transcriptional cell-to-cell variability of three groups of responsive genes with different functions: cytokines, transcription factors, and kinases and phosphatases (hereafter 'kinases'; Fig. 3c , Extended Data Fig. 8 ). In contrast to kinases and transcription factors, many cytokines display relatively high levels of cell-to-cell variability (Extended Data Fig. 9 ), being expressed only in a small subset of responding cells (Extended Data Fig. 10 ). This has previously been reported for several cytokines 29 . For example, IFNB is expressed in only a small fraction of cells infected with viruses or challenged with various stimuli 8, 11, 32 . Here, we find that cells show high levels of variability in expression of cytokines from several families (for example, IFNB, CXCL10 and CCL2).
Cell-to-cell variability of cytokines remains relatively high in comparison to kinases and transcription factors during a time course of 2, 4 and 8 h after dsRNA stimulation of fibroblasts (Extended Data Fig. 9 ). This pattern is similar across species, and can also be observed in LPS-stimulated phagocytes (Extended Data Fig. 9 ). Thus, the high variability of cytokines and their expression in a small fraction of stimulated cells across all time points is evolutionarily conserved.
Cytokines tended to be co-expressed in the same cells, raising the possibility that their expression is coordinated (see Supplementary Information and Supplementary Fig. 16 ). We also identified genes whose expression was correlated with cytokines in human fibroblasts and showed that their orthologues tend to be co-expressed with cytokines in other species. This set is enriched with genes known to be involved in cytokine regulation (Supplementary Table 5 ). For each gene studied in fibroblast dsRNA stimulation, the total number of TFBM matches in its H3K4me3 histone mark was divided by the length of the mark (human marks were used; n = 879 differentially expressed genes with ChIP-seq data). Highdivergence genes have higher TFBM density than low-divergence genes (one-sided Mann-Whitney test). b, Promoter sequence conservation and response divergence in fibroblast dsRNA stimulation. Sequence conservation values are estimated with phyloP7 for 500 base pairs upstream of the transcription start site (TSS) of the human gene. Mean conservation values of each of the 500 base pairs upstream of the TSS are shown for high-, medium-and low-divergence genes (n = 840 genes). Genes that are highly divergent have higher sequence conservation (one-sided Kolmogorov-Smirnov test). The 95% confidence interval for predictions from a linear model computed by geom_loess function is shown in grey. c, Comparison of divergence in response of genes with and without a TATA-box and a CGI in fibroblast dsRNA stimulation and phagocyte LPS stimulation. TATA-box matches and CGI overlaps were computed with respect to the TSS of human genes in fibroblasts (n = 955 genes), and to the TSS of mouse genes in phagocytes (n = 2,336). d, Distributions of divergence values of 9,753 expressed genes in fibroblasts, 955 dsRNA-responsive genes and different functional subsets of the dsRNAresponsive genes (each subset is compared with the set of 955 genes using a one-sided Mann-Whitney test and FDR-corrected P values are shown). e, Distributions of divergence values of 6,619 expressed genes in phagocytes, 2,336 LPS-responsive genes and different functional subsets of the LPSresponsive genes (each subset is compared with the set of 2,336 genes using a one-sided Mann-Whitney test and FDR-corrected P values are shown). Violin plots show the kernel probability density of the data. Boxplots represent the median, first quartile and third quartile with lines extending to the furthest value within 1.5 of the interquartile range (IQR). 
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As an example, we focused on the genes whose expression is positively correlated with the chemokine CXCL10 in at least two species (Fig. 3d ). This set includes four cytokines co-expressed with CXCL10 (in purple), as well as known positive regulators of the innate immune response and cytokine production (in blue), such as the viral sensors IFIH1 (also known as MDA5) and RIG-I (also known as DDX58) This is in agreement with previous evidence that IFNB expression is limited to cells in which important upstream regulators are expressed at sufficiently high levels 8, 11, 32 . Here, we show that this phenomenon of co-expression with upstream regulators applies to a wider set of cytokines and is conserved across species. Notably, cytokines were co-expressed not only with their positive regulators but also with genes that are known to act as negative regulators of cytokine expression or cytokine signalling (in red), suggesting that cytokine expression and function is tightly controlled at the level of individual cells.
The evolutionary landscape of innate immunity
Many immune genes, including several cytokines and their receptors, have been shown to evolve rapidly in coding sequence 3, 33 . However, it is not known how divergence in coding sequence relates to transcriptional divergence in innate immune genes. Using the set of 955 dsRNA-responsive genes in fibroblasts, we assessed coding sequence evolution in the three subsets of low-, medium-and high-divergence genes (as defined in Fig. 1c ).
We compared the rate at which genes evolved in their coding sequences with their response divergence by considering the ratio of non-synonymous (dN) to synonymous (dS) nucleotide substitutions. Genes that evolved rapidly in transcriptional response had higher coding sequence divergence (higher dN/dS values) than dsRNAresponsive genes with low response divergence ( Fig. 4a ).
Rapid gene duplication and gene loss have been observed in several important immune genes [34] [35] [36] [37] [38] [39] and are thought to be a result of pathogendriven pressure 40, 41 . We therefore tested the relationship between a gene's divergence in response and the rate at which the gene's family has expanded and contracted in the course of vertebrate evolution. We found that transcriptionally divergent dsRNA-responsive genes have higher rates of gene gain and loss ( Fig. 4b ) and consequently are also evolutionarily younger ( Fig. 4c, Supplementary Fig. 17 ).
Previous reports have suggested that proteins encoded by younger genes tend to have fewer protein-protein interactions (PPIs) within cells 42 . Indeed, we found that rapidly diverging genes tend to have fewer PPIs ( Fig. 4d ). Together, these results suggest that transcriptionally divergent dsRNA-responsive genes evolve rapidly through various mechanisms, including fast coding sequence evolution and higher rates of gene loss and duplication events, and that their products have fewer interactions with other cellular proteins than those of less divergent genes.
The interaction between pathogens and the host immune system is thought to be an important driving force in the evolution of both sides. We therefore investigated the relationship between transcriptional divergence and interactions with viral proteins by compiling a data set of known host-virus interactions in humans 6, 43, 44 . Notably, genes whose products had no known viral interactions showed higher response divergence than genes encoding proteins with viral interactions ( Fig. 4e ). Furthermore, the transcriptional divergence of genes targeted by viral immunomodulators 45 -viral proteins that subvert the host immune system-was lower still (Fig. 4e ). These observations suggest that viruses have evolved to modulate the immune system by interacting with immune proteins that are relatively conserved in their response. Presumably, these genes cannot evolve away from viral interactions, unlike host genes that are less constrained 46 .
The summary of our results in Fig. 4f highlights the differences in both regulatory and evolutionary characteristics between cytokines and other representative dsRNA-responsive genes. Cytokines evolve rapidly through various evolutionary mechanisms and have higher transcriptional variability across cells. By contrast, genes that are involved in immune response regulation, such as transcription factors and kinases, are more conserved and less heterogeneous across cells. These genes encode proteins that have more interactions with other cellular proteins, suggesting that higher constraints are imposed on their evolution. This group of conserved genes is more often targeted by viruses, revealing a relationship between host-pathogen dynamics and the evolutionary landscape of the innate immune response.
Discussion
Here, we have charted the evolutionary architecture of the innate immune response. We show that genes that diverge rapidly between . Genes classified as high-, medium-or low-divergence according to level of response divergence. Cell-to-cell variability values of high-divergence genes were compared with those of low-divergence genes (one-sided Mann-Whitney test). b, Comparison of cell-to-cell variability of genes with and without a TATA-box and a CGI, in fibroblast dsRNA stimulation and phagocyte LPS stimulation (one-sided Mann-Whitney test). Cell-to-cell variability values are from DM estimations of human fibroblasts stimulated with dsRNA for 4 h (n = 55 cells) and from mouse phagocytes stimulated with LPS for 4 h (n = 3,293 cells). c, Scatter plot showing divergence in response to dsRNA in fibroblasts across species and transcriptional cell-to-cell variability in human cells following 4 h of dsRNA stimulation (n = 684 dsRNA-responsive genes). Purple, cytokines; green, transcription factors; beige, kinases. The distributions of divergence and variability values of these groups are shown above and to the right of the scatter plot, respectively. d, A network showing genes that correlate positively in expression with the chemokine gene CXCL10 across cells (Spearman correlation, ρ > 0.3), in at least two species (one of which is human), following dsRNA treatment in fibroblasts (based on n = 146, 74, 175 and 170 human, macaque, rat and mouse cells, respectively). Purple, cytokines; red, positive regulators of cytokine expression; blue, negative regulators. Colours of lines, from light to dark grey, reflect the number of species in which this pair of genes was correlated. Boxplots represent the median, first quartile and third quartile with lines extending to the furthest value within 1.5 × IQR. Article reSeArcH species show higher levels of variability in their expression across individual cells than genes that diverge more slowly. Both of these characteristics are associated with a similar promoter architecture, enriched in TATA-boxes and depleted of CGIs. Notably, such promoter architecture is also associated with the high transcriptional range of genes during the immune response. Thus, transcriptional changes between conditions (stimulated versus unstimulated), species (transcriptional divergence), and individual cells (cell-to-cell variability) may all be mechanistically related to the same promoter characteristics. In yeast, TATA-boxes are enriched in promoters of stress-related genes, displaying rapid transcriptional divergence between species and high variability in expression 30, 47 . This finding suggests intriguing analogies between the mammalian immune and yeast stress responses-two systems that have been exposed to continuous changes in external stimuli during evolution.
We have also shown that genes involved in regulation of the immune response-such as transcription factors and kinases-are relatively conserved in their transcriptional responses. These genes might be under stronger functional and regulatory constraints, owing to their roles in multiple contexts and pathways, which would limit their ability to evolve. This limitation could represent an Achilles' heel that is used by pathogens to subvert the immune system. Indeed, we found that viruses interact preferentially with conserved proteins of the innate immune response. Cytokines, on the other hand, diverge rapidly between species, owing to their promoter architecture and because they have fewer constraints imposed by intracellular interactions or additional Response divergence
Cytokines and chemokines Fig. 1c ), cell-to-cell variability (as in Fig. 3a Article reSeArcH non-immune functions. We therefore suggest that cytokines represent a successful host strategy to counteract rapidly evolving pathogens as part of the host-pathogen evolutionary arms race.
Cytokines also display high cell-to-cell variability and tend to be co-expressed with other cytokines and cytokine regulators in a small subset of cells, and this pattern is conserved across species. As prolonged or increased cytokine expression can result in tissue damage [48] [49] [50] , restriction of cytokine production to only a few cells may enable a rapid, but controlled, response across the tissue to avoid long-lasting and potentially damaging effects.
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Article reSeArcH

MEthodS
Ethical compliance. This project was approved by the Wellcome Sanger Institute Animal Welfare and Ethical Review Body, and complied with all relevant ethical regulations regarding animal research and human studies. Human cells were obtained from the Hipsci project 51 , where they were collected from volunteers recruited from the NIHR Cambridge BioResource (written consent was given). Human skin profiling was performed in accordance with protocols approved by the Newcastle Research Ethics Committee (REC approval 08/H0906/95+5). Macaque skin samples were obtained from animals assigned to unrelated noninfectious studies, provided by Public Health England's National Infection Service in accordance with Home Office (UK) guidelines and approved by the Public Health England Ethical Review Committee under an appropriate UK Home Office project license. Cross-species dermal fibroblast stimulation with dsRNA and IFNB. Tissue culture. We cultured primary dermal fibroblasts from low passage cells (below 10) that originated from females from four different species (human (European ancestry), rhesus macaque, C57BL/6 (black 6) mouse and brown Norway rat). All skin samples were taken from shoulders. Stimulation experiments and library preparations were done in identical conditions across all species and for all genomics techniques. Details on the numbers of individuals used in each technique are listed in each technique's section and in Supplementary Table 1 .
Human cells were obtained from the Hipsci project 51 (http://www.hipsci.org/). Rhesus macaque cells were extracted from skin tissues that were incubated for 2 h with 0.5% collagenase B (Roche; 11088815001) after mechanical processing, and then filtered through 100-µm strainers before being plated and passaged before cryo-banking. Rodent cells were obtained from PeloBiotech where they were extracted using a similar protocol. In vitro cultured fibroblasts from all four species resemble a particular in vivo cluster of dermal fibroblasts (see Supplementary  Information ). Cells were not tested for mycoplasma contamination.
Prior to stimulation, cells were thawed and grown for several days in ATCC fibroblast growth medium (Fibroblast Basal Medium (ATCC, ATCC-PCS-201-030) with Fibroblast Growth Kit-Low serum (ATCC, PCS-201-041) (supplemented with Primocin (Invivogen, ant-pm-1) and penicillin/streptomycin (Life Technologies, 15140122)) -a controlled medium that has proven to provide good growing conditions for fibroblasts from all species, with slightly less than 24 h doubling times. About 18 h before stimulation, cells were trypsinized, counted and seeded into 6-well plates (100,000 cells per well). Cells were stimulated as follows: (1) stimulated with 1 µg/ml high-molecular mass poly(I:C) (Invivogen,tlrl-pic) transfected with 2 µg/ml Lipofectamin 2,000 (ThermoFisher, 11668027); (2) mock transfected with Lipofectamin 2,000; (3) stimulated with 1,000 IU of IFNB for 8 h (human IFNB: 11410-2 (for human and macaque cells); rat IFNB: 13400-1; mouse IFNB: 12401-1; all IFNs were obtained from PBL, and had activity units based on similar virological assays); or (4) left untreated. Interferon stimulation was used as a control, to study how genes that were upregulated in the secondary wave of the innate immune response diverge between species.
Additional human and mouse samples were stimulated with 1,000 IU of cross-mammalian IFN (CMI, or Universal Type I IFN Alpha, PBL, 11200-1). The latter stimulation was done to assess the effects of species-specific and batchspecific IFNB.
In all of the above-mentioned stimulations, we used a longer time course for single-cell RNA-seq than for bulk RNA-seq, for two main reasons: (1) in the bulk, we chose to focus on one main stimulation time point for simplicity and to obtain an intuitive fold-change between stimulated and unstimulated conditions; (2) in single cells, when studying cell-to-cell variability, we chose to profile, in addition to the main stimulation time point, cells in earlier and later stages of the response. This is important for studying how the dynamics and magnitude of the response affect gene expression variability between responding cells.
The poly(I:C) we used tested negative for the presence of bacterial beta-endotoxin using a coagulation test (PYROGENT Plus, 0.06 EU/ml sensitivity, N283-06). Bulk RNA-seq: library preparation and sequencing. For bulk transcriptomics analysis, cells from individuals from different species were grown in parallel and stimulated with dsRNA, IFNB (and cross-mammalian IFN) and their respective controls. In total, samples from 6 humans, 6 macaques, 3 mice and 3 rats were used. Total RNA was extracted using the RNeasy Plus Mini kit (Qiagen, 74136), using QIAcube (Qiagen). RNA was then measured using a Bioanalyzer 2100 (Agilent Technologies), and samples with RIN < 9 were excluded from further analysis (one macaque sample stimulated with poly(I:C) and its control).
Libraries were produced using the Kapa Stranded mRNA-seq Kit (Kapa Biosystems, KK8421). The Kapa library construction protocol was modified for automated library preparation by Bravo (Agilent Technologies). cDNA was amplified in 13 PCR cycles, and purified using Ampure XP beads (Beckman Coulter, A63882) (1.8× volume) using Zephyr (Perkin Elmer). Pooled samples were sequenced on an Illumina HiSeq 2500 instrument, using paired-end 125-bp reads.
ChIP-seq: library preparation and sequencing. Samples from three individuals from each of the four species were grown and stimulated (with poly(I:C) for 4 h or left untreated, as described above) in parallel to samples collected for bulk RNA-seq. Following stimulation, samples were crosslinked in 1% HCHO (prepared in 1× DPBS) at room temperature for 10 min, and HCHO was quenched by the addition of glycine at a final concentration of 0.125 M. Cells were pelleted at 4 °C at 2,000g, washed with ice-cold 1× DPBS twice, and snap-frozen in liquid nitrogen. Cell pellets were stored at -80 °C until further stages were performed. ChIPmentation was performed according to version 1.0 of the published protocol 52 with a few modifications (see additional details in Supplementary Methods).
Library preparation reactions contained the following reagents: 10 µl purified DNA (from the above procedure), 2. When sorting with MoFlo, a pressure of 15 psi was used with a 150-µm nozzle, using the 'Single' sort purity mode. Dead or late-apoptosis cells were excluded using propidium iodide at 1 µg/ml (Sigma, Cat Number P4170) and single cells were selected using FSC W versus FSC H. When sorting with INFLUX, a pressure of 3 psi was used with a 200-µm nozzle, with the 'single' sort mode. Dead or late-apoptosis cells were excluded using 100 ng/ml DAPI (4′,6-diamidino-2phenylindole) (Sigma, D9542). DAPI was detected using the 355-nm laser (50 mW), using a 460/50 nm bandpass filter. Rhodamine was detected using the 561-nm laser (50mW), using a 585/29 nm bandpass filter. Single cells were collected using FSC W versus FSC H. Library preparation from full-length RNA from single cells and sequencing. Sorted plates were processed according to the Smart-seq2 protocol 53 . Oligo-dT primer (IDT), dNTPs (ThermoFisher, 10319879) and ERCC RNA Spike-In Mix (1:25,000,000 final dilution, Ambion, 4456740) were added to each well, and reverse transcription (using 50 U SmartScribe, Clontech, 639538) and PCR were performed following the original protocol with 25 PCR cycles. cDNA libraries were prepared using Nextera XT DNA Sample Preparation Kit (Illumina, FC-131-1096), according to the protocol supplied by Fluidigm (PN 100-5950 B1). Quality Checks on cDNA were done using a Bioanalyser 2100 (Agilent Technologies). Libraries were quantified using the LightCycler 480 (Roche), pooled and purified using AMPure XP beads (Beckman Coulter) with Hamilton 384 head robot (Hamilton Robotics). Pooled samples were sequenced on an Illumina HiSeq 2500 instrument, using paired-end 125-bp reads. Read mapping to annotated transcriptome. For bulk RNA-seq samples, adaptor sequences and low-quality score bases were first trimmed using Trim Galore (version 0.4.1) (with the parameters '-paired-quality 20-length 20 -e 0.1-adapter AGATCGGAAGAGC'). Trimmed reads were mapped and gene expression was quantified using Salmon (version 0.6.0) 54 
with the following command: 'salmon quant -i [index_file_directory] -l ISR -p 8-biasCorrect-sensitive-extraSensitive -o [output_directory] -1 -g [ENSEMBL_transcript_to_gene_file]
-useFSPD-numBootstraps 100' . Each sample was mapped to its respective species' annotated transcriptome (downloaded from ENSEMBL, version 84: GRCh38 for human, MMUL_1 for macaque, GRCm38 for mouse, Rnor_6.0 for rat). We included only the set of coding genes (*.cdna.all.fa files). We removed annotated secondary haplotypes of human genes by removing genes with 'CHR_HSCHR' . Quantifying differential gene expression in response to dsRNA. To quantify differential gene expression between treatment and control for each species and for each treatment separately, we used edgeR (version 3.12.1) 55 using the rounded estimated counts from Salmon. This was done only for genes that had a significant level of expression in at least one of the four species (TPM >3 in at least N -1 libraries, where N is the number of different individuals we have for this species with libraries that passed quality control, and TPM is transcripts per million). Differential Article reSeArcH expression analysis was performed using the edgeR exact test, and P values were adjusted for multiple testing by estimating the false discovery rate (FDR). Conservation and divergence in immune response: fold-change-based analysis. We compared the overall change in response to treatment (dsRNA or IFNB) between pairs of species, by computing the Spearman correlation of the fold-change in response to treatment across all one-to-one orthologues that were expressed in at least one species (Extended Data Fig. 1a-h ). Fold-change was calculated with edgeR, as described above. Spearman correlations of all expressed genes appear in grey. Correlations of the subset of differentially expressed genes (genes with FDR-corrected P < 0.01 in at least one of the compared species) appear in black.
In Extended Data Fig. 1a -c, we show comparisons in response to dsRNA. In Extended Data Fig. 1d -f, we show comparisons in response to IFNB, which we use here to study the similarity of the secondary immune response between species.
We constructed a tree based on a gene's change in expression in response to dsRNA and to IFNB, using expressed genes that had one-to-one orthologues across all four species and were expressed in at least one species in at least one condition (Extended Data Fig. 1i ). We used hierarchical clustering, with the hclust command from the stats R package, with the distance between samples computed as 1 -ρ, where ρ is the pairwise Spearman correlation between each pair of species mentioned above (a greater similarity, reflected in a higher correlation, results in a smaller distance) and 'average' as the clustering method.
The above-mentioned analyses focus on one-to-one orthologues between the compared species. In Supplementary Table 6 , we quantify the similarity in response between species (based on Spearman correlations) when adding genes with one-to-many orthologues. Quantifying gene expression divergence in response to immune challenge. To quantify transcriptional divergence in immune response between species, we focus on genes that have annotated one-to-one orthologues across the studied species (human, macaque, mouse and rat). 9,753 of the expressed genes have annotated one-to-one orthologues in all four species, out of which 955 genes are differentially expressed in human in response to dsRNA treatment (genes with an FDR-corrected P < 0.01).
We define a measure of response divergence (based on a previous study 56 ) by calculating the differences between the fold-change estimates across the orthologues:
This measure takes into account the structure of the phylogeny, and gives a relative measure of divergence in response across all genes with one-to-one orthologues.
To consider differences between species, we focus on between-clade differences (primates versus rodents), rather than on within-clade differences. In this way, we map the most significant macro-evolutionary differences along the longest branches of our four-species phylogeny. In addition, averaging within clades acts as a reduction of noise 56 .
We compared this divergence measure to two other measures that use models (and incorporate both between-and within-clade divergence) and found a strong correlation between the divergence estimates across the three approaches ( Supplementary Figs. 3, 4) .
In most of the subsequent analyses, we focus on the 955 dsRNA-responsive genes: genes that were differentially expressed in response to dsRNA (genes that have an FDR-corrected P < 0.01 in human, and have annotated one-to-one orthologues in the other three species). For some of the analyses, we split these 955 genes based on quartiles, into genes with high, medium and low divergence (Fig. 1c) .
We also studied how imprecisions in the fold-change estimates affected the response divergence estimates and subsequent analyses ( Supplementary Figs. 5, 6 ).
Comparison of response divergence between different functional groups.
To compare the divergence rates between sets of dsRNA-responsive genes that have different functions in the innate immune response, we split these 955 genes into the following functional groups (all groups are mutually exclusive, and any gene that belongs to two groups was excluded from the latter group; human gene annotations were used).
We first grouped genes by annotated molecular functions: viral sensors (genes that belong to one of the GO categories: GO:0003725 (dsRNA binding), GO:0009597 (detection of virus), and GO:0038187 (pattern recognition receptor activity)); cytokines, chemokines and their receptors (GO:0005125 (cytokine activity), GO:0008009 (chemokine activity), GO:0004896 (cytokine receptor activity), and GO:0004950 (chemokine receptor activity)); transcription factors (taken from the Animal Transcription Factor DataBase (version 2.0) 57 ); chromatin modulators (GO:0016568 (chromatin modification), GO:0006338 (chromatin remodelling), GO:0003682 (chromatin binding), and GO:0042393 (histone binding)); kinases and phosphatases (GO:0004672 (protein kinase activity) and GO:0004721 (phosphoprotein phosphatase activity)); ligases and deubiquitinases (GO:0016579 (protein deubiquitination), GO:0004842 (ubiquitin-protein transferase activity) and GO:0016874 (ligase activity)); and other enzymes (mostly involved in metabolism rather than regulation: GO:0003824 (catalytic activity)). The divergence response values of these functional subsets were compared to the entire group of 955 dsRNA-responsive genes (Fig. 2d, e ).
Next, we grouped genes by biological processes that are known to be important in the innate immune response: antiviral defence (GO:0051607 (defence response to virus)); inflammation (GO:0006954 (inflammatory response)); apoptosis (GO:0006915 (apoptotic process)); and regulation (GO annotations related to regulation of innate immune response pathways include only few genes. We thus used as the group of genes related to regulation, the merged group of genes that are annotated as transcription factors, chromatin modulators, kinases and phosphates or ligases and deubiquitinases, since all these groups include many genes that are known to regulate the innate immune response.)
Gene lists belonging to the mentioned GO annotations were downloaded using QuickGo 58 . The distribution of response divergence values for each of the functional groups was compared with the distribution of response divergence of the entire set of dsRNA-responsive genes. Cytokines, chemokines and their receptors are merged in Fig. 2d, e, 3c . Analogous comparisons of functional groups in IFNB response (with 841 IFNB-responsive genes) are shown in Supplementary Fig. 1 . See additional analyses in Supplementary Information. Alignment and peak calling of ChIP-seq reads. ChIP-seq reads were trimmed using trim_galore (version 0.4.1) with '-paired-trim1-nextera' flags. The trimmed reads were aligned to the corresponding reference genome (hg38 for human, rheMac2 for macaque, mm10 for mouse, rn6 for rat; all these genomes correspond to the transcriptomes used for RNA-seq mapping) from the UCSC Genome Browser 59 using bowtie2 (version 2.2.3) with default settings 60 . In all four species, we removed the Y chromosome. In the case of human, we also removed all alternative haplotype chromosomes. Following alignment, low-confident mapped and improperly paired reads were removed by samtools 61 with '-q 30 -f 2' flags.
Enriched regions (peaks) were called using MACS2 (v.2.1.1) 62 with a corrected P value cutoff of 0.01 with '-f BAMPE -q 0.01 -B-SPMR' flags, using input DNA as control. The genome sizes (the argument for '-g' flag) used were 'hs' for human, 'mm' for mouse, 3.0 × 10 9 for macaque and 2.5 × 10 9 for rat. Peaks were considered reproducible when they were identified in at least two of the three biological replicates and overlapped by at least 50% of their length (non-reproducible peaks were excluded from subsequent analyses). Reproducible peaks were then merged to create consensus peaks from overlapping regions of peaks from the three replicates by using mergeBed from the bedtools suite 63 . Gene assignment and conservation of active promoters and enhancers. We subsequently linked human peaks with the genes they might be regulating as follows: H3K4me3 consensus peak was considered the promoter region of a given gene if its centre was between 2 kb upstream and 500 bp downstream of the annotated TSS of the most abundantly expressed transcript of that gene.
Similarly, H3K27ac was considered the enhancer region of a given gene if its centre was in a distance above 1 kb and below 1 Mb, and there was no overlap (of 1 bp or more) with any H3K4me3 peak.
In each case where, based on the distance criteria, more than a single peak was linked to a gene (or more than a single gene was linked to a peak), we took only the closest peak-gene pair (ensuring that each peak will have up to one gene and vice versa).
To compare active promoters and enhancers between species, we excluded any human peak that could not be uniquely mapped to the respective region in the other species. This was done by looking for syntenic regions of human peaks in the other three species by using liftOver 64 , and removing peaks that had either unmapped regions or more than one mapped region in the compared species. We considered syntenic regions with at least 70% sequence similarity between the species (minMatch = 0.7, and 0.8 in the case of human-macaque comparison), with a minimal length (minSizeQ and minSizeT) corresponding to the length of the shortest peak (128 bp in H3K4 and 142 bp in H3K27).
We defined an active human promoter or enhancer as conserved if a peak was identified in the corresponding region of the other species (we repeated this analysis by comparing human with each of the other three species separately). We compared the occurrence of conserved promoters and enhancers in genes that are highly divergent in response to dsRNA with low-divergence genes, and used Fisher's exact test to determine the statistical significance of the observed differences between high-and low-divergence genes (Extended Data Fig. 2) . Promoter sequence analysis. To calculate the total number of transcription factor binding motifs in a gene's active promoter region, we downloaded the nonredundant JASPAR core motif matrix (pfm_vertebrates.txt) from the JASPAR 2016 server 65 and searched for significant matches for these motifs using FIMO 66 in human H3K4me3 peaks. The TFBM density of peaks was calculated by dividing the total number of motif matches in a peak by the peak's length. TBFM density values in human H3K4me3 peaks linked with high-and low-divergence genes were compared (Fig. 2a) .
PhyloP7 values were used to assess promoter sequence conservation 67 . Sequence conservation quantification was performed by taking the estimated nucleotide substitution rate for each nucleotide along the promoter sequence (500 bp upstream of the TSS of the relevant human gene). When several annotated transcripts existed, the TSS of the most abundantly expressed transcript was used (based on bulk RNA data). The substitution rate values from all genes were aligned, based on their TSS position, and a mean for each of the 500 positions was calculated separately for the group of genes with high, medium and low response divergence. The two-sample Kolmogorov-Smirnov test was used to compare the paired distribution of rates between the means of the high-divergence and low-divergence sets of genes. To plot the mean values of the three sets of divergent genes, the geom_smooth function from the ggplot2 R package was used with default parameters (with loess as the smoothing method) (Fig. 2b) .
Human CGI annotations were downloaded from the UCSC genome table browser (hg38), and CGI genes were defined as those with a CGI overlapping their core promoter (300 bp upstream of the TSS reference position, and 100 bp downstream of it, as suggested previously 18 ). Genes were defined as having a TATA box if they had a significant match to the Jaspar TATA box matrix (MA0108.1) in the 100 bp upstream of their TSS by FIMO 66 with default settings (we used a 100 bp window owing to possible inaccuracies in TSS annotations). We note that only 28 out of 955 dsRNA-responsive genes had a matching TATA-box motif in this region. For both TATA and CGI analyses, the promoter sequences of the human orthologues were used. Read mapping and quality control of scRNA-seq (full-length RNA). Gene expression was quantified in a manner similar to the quantification for bulk transcriptomics libraries described above. Low-quality cells were filtered using quality control criteria (cells with at least 100,000 mapped reads, with at least 2,000 expressed genes with TPM > 3, with ERCC < 10% and MT < 40%, where ERCC and MT refer to reads mapped to synthetic RNA Spike-In genes and mitochondrial genes). This quality control filtering resulted in 240 cells from a first biological replicate, including two technical replicates (with a time course of 0, 4, 8 h). In a second larger biological replicate (with a dsRNA stimulation time course of 0, 2, 4, 8 h), 728 cells passed quality control. Results throughout the manuscript relate to the second cross-species biological replicate in which a higher proportion of cells passed QC, and the lower-quality first replicate data were not considered further. Cell-to-cell variability analysis. To quantify the biological cell-to-cell variability of genes, we applied the DM (Distance to Median) approach-an established method, which calculates the cell-to-cell variability in gene expression while accounting for confounding factors such as gene expression level 30 . This is done by first filtering out genes that are expressed at low levels: for Smart-seq2 data we included only genes that had an average expression of at least 10 size-factor normalized reads (except for Extended Data Fig. 9a , in which we reduced the threshold to 5, to allow a larger number of genes to be included in the comparisons). This procedure was done to filter genes that displayed higher levels of technical variability between samples owing to low expression. Second, to account for gene expression level, the observed cell-to-cell variability of each gene was compared with its expected variability, based on its mean expression across all samples and in comparison with a group of genes with similar levels of mean expression. This DM value is also corrected by gene length (in the case of Smart-seq2 data), yielding a value of variability that can be compared across genes regardless of their length and mean expression values 68 . As a second approach, we used BASiCS 69, 70 (see Supplementary Information) .
We note that the relationship observed in Fig. 3a between response divergence and cell-to-cell variability is not an artefact, stemming from differences in expression levels: (A) With respect to cell-to-cell variability, a gene's expression level is controlled for by DM calculations, where expression level is regressed by using a running median ( Supplementary Fig. 14). (B) Similarly, we can regress the expression level measured in bulk RNA-seq from the quantified response divergence by subtracting the running median of expression from the divergence estimates. When repeating the analysis comparing cell-to-cell variability versus regressed response divergence, the relationship between the two is maintained ( Supplementary Fig. 15 ). Cytokine co-expression analysis. For the chemokine gene CXCL10, we built a network (using CytoScape 71 ) of genes that correlate with CXCL10 in dsRNAstimulated human fibroblasts and in at least one more species, using genes with a Spearman correlation value above 0.3 (see Fig. 3d and Supplementary Information).
Coding sequence evolution analysis. The ratio dN/dS (non-synonymous to synonymous codon substitutions) of human genes across the mammalian clade was obtained from a previous study that used orthologous genes from 29 mammals 72 . Distributions of dN/dS values were computed for each of the three groups of genes with low, medium and high divergence in response to dsRNA, and are plotted in Fig. 4a . Rate of gene gain and loss analysis. The significance at which a gene's family has experienced a higher rate of gene gain and loss in the course of vertebrate evolution, in comparison with other gene families, was retrieved from ENSEMBL 73 . The statistics provided by ENSEMBL are calculated using the CAFE method 74 , which estimates the global birth and death rate of gene families and identifies gene families that have accelerated rates of gain and loss. Distributions of the P values from this statistic were computed for each of the three groups of genes with low, medium and high divergence in response to dsRNA and are plotted as the negative logarithm values in Fig. 4b . Gene age analysis. Gene age estimations were obtained from ProteinHistorian 75 . To ensure that the results were not biased by a particular method of ancestral protein family reconstruction or by specific gene family assignments, we used eleven different estimates for mammalian genes (combining five different databases of protein families with two different reconstruction algorithms for age estimation, as well as an estimate from the phylostratigraphic approach). For each gene, age was defined with respect to the species tree, where a gene's age corresponds to the branch in which its family is estimated to have appeared (thus, larger numbers indicate evolutionarily older genes).
Data for gene age in comparison with divergence in response to dsRNA are shown in Fig. 4c (using Panther7 phylogeny and Wagner reconstruction algorithm) and in Supplementary Fig. 17a (for all 11 combinations of gene family assignments and ancestral family reconstructions). See additional analyses in Supplementary Information. Cellular protein-protein interaction analysis. Data on the number of experimentally validated PPIs for human genes were obtained from STRING (version 10) 76 . Distributions of PPIs for genes with low, medium and high divergence in response to dsRNA are plotted in Fig. 4d . Host-virus interaction analysis. Data on host-virus protein-protein interactions were downloaded from the VirusMentha database 43 , and combined with two additional studies that have annotated host-virus protein-protein interactions 6, 44 . We split the 955 dsRNA-responsive genes into genes with known viral interactions (genes whose protein products were reported to interact with at least one viral protein), and genes with no known viral interactions: 'viral interactors' and 'no viral interactions' , respectively, in Fig. 4e . In addition, we define a subset of genes within the viral interactors set: those known to interact with viral proteins that are immunomodulators (proteins known to target the host immune system and modulate its response 45 ).
We note that the results presented in Fig. 4e are in agreement with previous analyses that are based on all human genes and on coding sequence evolution 46 . However, the overlap in the sets of genes between the previous analyses and the one presented here is small (for example, in one published study 46 there were 535 human genes with known interactions with pathogens, 57 of which overlap with the 955 genes that are the basis of the current analysis).
Additional experiments with human fibroblasts and human skin tissue.
Additional experiments were performed with human dermal fibroblasts and with cells extracted from human skin tissues to study in greater detail the relationship between response divergence across species and cell-to-cell variability. See Supplementary Methods and Supplementary Discussion for details. Cross-species bone marrow-derived phagocyte stimulation with LPS and dsRNA. Tissue culture. Primary bone marrow-derived mononuclear phagocytes originating from females of four different species (black 6 mouse, brown Norway rat, rabbit and pig) and cultured with GM-CSF, were obtained from PeloBiotech. Twenty-four hours before the start of the stimulation time course, cells were thawed and split into 12-well plates (500,000 cells per well). Cells were stimulated with: (1) 100 ng/ml LPS (Invivogen, tlrl-smlps), or with (2) 1 µg/ml high-molecular mass poly(I:C) (Invivogen, tlrl-pic) transfected with 2 µl/ml Lipofectamin 2,000 (ThermoFisher, 11668027). LPS stimulation time courses of 0, 2, 4, 6 h were performed for all species. Poly(I:C) stimulations were performed for rodents for 0, 2, 4, 6 h. We also processed cells for bulk RNA-seq for 0 and 4 h stimulation time points. Details on the individuals used in each technique are listed in Supplementary Table 2 . Library preparation for single cells using microfluidic droplet cell capture. Following stimulation, cells were collected using Cell Dissociation Solution Non-enzymatic (Sigma-Aldrich, C5914), washed and resuspended in 1 × PBS with 0.5% (w/v) BSA. Cells were then counted and loaded on the 10x Chromium machine aiming for a targeted cell recovery of 5,000 cells according to the manual. Libraries were prepared following the Chromium Single Cell 3′ v2 Reagent Kit Manual 77 . Libraries were sequenced on an Illumina HiSeq 4000 instrument with 26 bp for read 1 and 98 bp for read 2. Library preparation and sequencing for bulk RNA-seq. Total RNA was extracted and libraries were prepared as described in the fibroblasts section. Pooled samples were sequenced on an Illumina HiSeq 4000 instrument, using paired-end 75-bp reads. Quantifying gene expression in bulk RNA-seq data. Adaptor sequences and low-quality score bases were trimmed using Trim Galore (version 0.4.1). Trimmed reads were mapped and gene expression was quantified using Salmon: (version 0.9.1) 54 with the following command: 'salmon quant -i [index_file_directory] / -l ISR -p 8-seqBias-gcBias-posBias -q -o [output_directory] -1 -g [ENSEMBL_ transcript_to_gene_file]-useVBOpt-numBootstraps 100' . Mouse samples were mapped to mouse transcriptome (ENSEMBL, version 84). We note that we used Article reSeArcH the bulk data only for TSS analysis. For differential expression analysis, we used an in silico bulk from the single-cell data (see below). Quantifying gene expression in microfluidic droplet cell capture data. Microfluidic droplet cell capture data was first quantified using 10x Genomics' Cell Ranger Single-Cell Software Suite (version 2.0, 10× Genomics Inc.) 77 against the relevant genome (ENSEMBL, version 84). We removed cells with fewer than 200 genes or more than 10% mitochondrial reads. To remove potential doublets, we excluded the top 10% of cells expressing the highest numbers of genes. Genes expressed in less than 0.5% of the cells were excluded from the calculations. We then filtered cells that expressed fewer than 10% of the total number of filtered genes.
Since bone marrow-derived phagocytes may include secondary cell populations, we focused our analysis on the major cell population. We identified clusters within each data set, using the Seurat 78 functions RunPCA, followed by FindClusters (using 20 dimensions from the PCA, default perplexity and a resolution of 0.1) and have taken the cells belonging to the largest cluster for further analysis, resulting in a less heterogeneous population of cells. A lower resolution of 0.03 was used for rabbit-LPS4, rabbit-LPS2, mouse-PIC2, mouse-PIC4; and 0.01 for rabbit-LPS6. Quantifying gene expression divergence in response to immune challenge. We created an in silico bulk table by summing up the UMIs of the post-QC single cells belonging to the largest cluster of cells, in each of the samples. We then used the three replicates in unstimulated conditions and in 4 h LPS stimulation to perform a differential expression analysis using DESeq2 79 Wald test, and P values were adjusted for multiple testing by estimating the FDR. A similar procedure was performed with mouse and rat dsRNA stimulation (with 4 h dsRNA stimulation versus unstimulated conditions).
To quantify transcriptional divergence in immune response between species, we focused on genes that have annotated one-to-one orthologues across the studied species.
We define a measure of response divergence by calculating the differences between the fold-change estimates across the orthologues: response diver- 2 ]. For each gene, the fold-change in the outer group (pig), is subtracted from the fold-change in the orthologues of the three glires (mouse, rat and rabbit), and the average of the square values of these subtractions is taken as the response divergence measure. In most of the analyses, we focus on the 2,336 LPS-responsive genes-genes that are differentially expressed in response to LPS (genes that have an FDR-corrected P < 0.01 in mouse, and have annotated one-to-one orthologues in the other three species). Promoter elements, gene function and cell-to-cell variability analyses. Promoter elements (TATA and CGIs), gene function and cell-to-cell variability analyses were performed as described in the fibroblasts section. Mouse genes were used as the reference for gene function and TSS annotations. For variability analysis, we used one representative replicate out of three. Statistical analysis and reproducibility. Statistical analyses were done with R version 3.3.2 for Fisher's exact test, two-sample Kolmogorov-Smirnov test and Mann-Whitney test. Data in boxplots represent the median, first quartile and third quartile with lines extending to the furthest value within 1.5 of the interquartile range (as implemented by the R function geom_boxplot). Violin plots show the kernel probability density of the data (as implemented by the R function geom_violin).
All cross-species bulk RNA-seq replicates were successful, except for one macaque individual in which the treated sample had a low RNA quality and was removed from the analysis (along with the matching control). All cross-species ChIP-seq replicates were successful. Cross-species scRNA-seq of fibroblasts was performed in two biological replicates. Results throughout the manuscript relate to the second cross-species biological replicate, for which a higher proportion of cells passed technical quality control. Three out of three replicates for each species and condition were successful when preparing single-cell libraries for mononuclear phagocytes, except for two libraries that failed at the emulsion preparation stage. Two out of two replicates of single-cell in situ RNA hybridization assay were performed and both are shown. Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper.
Code availability. Scripts for major analyses are available at https://github.com/ Teichlab/innate_evo. Extended Data Fig. 1 | Fibroblast response to dsRNA and IFNB across species. To study the similarity in response to treatment across species, we plotted the fold-change values of all expressed genes (with one-to-one orthologues) between pairs of species (human-macaque, mouse-rat and human-mouse) in response to dsRNA (poly(I:C)) (a-c). As a control, we performed the same procedure with IFNB stimulations (d-f). Foldchanges were inferred from differential expression analyses, determined by the exact test in the edgeR package 6 and based on n = 6, 5, 3 and 3 individuals from human, macaque, rat and mouse, respectively. Spearman correlations between all expressed one-to-one orthologues are shown in grey, Spearman correlations between the subset of differentially expressed genes (FDR-corrected P < 0.01 in at least one species) appear in black. Number of genes shown is n = 11,035, 11,005, 11,137, 10,851, 10,826 and 10,957 in a-f, respectively. Genes are coloured blue if they were differentially expressed (FDR-corrected P < 0.01) in both species, purple if they were differentially expressed in only one species, or red if they were not differentially expressed. g, h, Density plots of ratio of fold-change in response to dsRNA or to IFNB. g, Comparison between human and macaque orthologues in dsRNA response. h, Comparison between human and mouse orthologues in IFNB response. i, Dendrogram based on the fold-change in response to dsRNA or to IFNB across 9,835 one-to-one orthologues in human, macaque, rat and mouse. . Chromatin marks were linked to genes on the basis of their proximity to the gene's TSS. Chromatin marks were obtained from n = 3 individuals in each of the four species, from fibroblasts stimulated with dsRNA or left untreated. The statistics are based on n = 855, 818 and 813 human genes that have a linked H3K4me3 mark with a syntenic region in macaque, rat and mouse, respectively (a); and on n = 326, 241 and 242 human genes that have a linked H3K27ac mark with a syntenic region in macaque, rat and mouse, respectively (b). Each panel shows the fraction of conserved marks between human and macaque, rat or mouse, in genes that have high, medium and low divergence in their transcriptional response.
Data availability
Article reSeArcH
In each column, the histone mark's signal was compared between human and the syntenic region in one of the three other species. If an active mark was found in the corresponding syntenic region, the linked gene was considered to have a conserved active mark (promoter or enhancer). The fractions of genes with conserved promoters (or enhancers) in each pair of species were compared between high-and low-divergence genes using a one-sided Fisher's exact test. When comparing active promoter regions of high-versus low-divergence genes, we observe that low-divergence genes have a significantly higher fraction of conserved marks in rodents. This suggests an agreement between divergence at the transcriptional and chromatin levels in active promoter regions. In active enhancer regions, we do not observe these patterns, suggesting that the major contribution to divergence comes from promoters. Fig. 3 | Comparison of response divergence of genes containing various promoter elements. Comparison of response divergence between genes with and without a TATA-box and a CGI. Left, fibroblasts (n = 14, 14, 633 and 294 differentially expressed genes with only TATA-box element, with both CGI and TATA-box elements, with only CGI, and with neither element in their promoters, respectively); right, phagocytes (n = 13, 29, 1,718 and 576 differentially expressed genes with only a TATA-box element, with both CGI and TATA-box elements, with only a CGI, and with neither element in their promoters, respectively). Genes with a TATA-box without a CGI have higher response divergence than genes with both elements. Genes with a CGI but without a TATAbox diverge more slowly than genes with both elements. Genes with both elements do not differ significantly in their divergence from genes lacking both elements (one-sided Mann-Whitney test). Data in boxplots represent the median, first quartile and third quartile with lines extending to the furthest value within 1.5 of the IQR. The percentage of expressing cells is divided into 13 bins (x-axis). The y-axis represents the fraction of genes from this gene class (for example, cytokines) that are expressed in each bin (for example, in human, nearly 30% of the cytokine genes (y-axis) are expressed in the first bin, corresponding to expression in fewer than 8% of cells).
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